PDB ligand accession: n/a
DrugBank: DB04855
InChI Key:
SMILES: CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
# | DrugDomain Data | UniProt Accession | Protein name | Drug Action | Affinity data |
---|---|---|---|---|---|
1 | P08913_DB04855 | P08913 | Alpha-2A adrenergic receptor | antagonist | |
2 | Q13698_DB04855 | Q13698 | Voltage-dependent L-type calcium | inhibitor | |
3 | P54284_DB04855 | P54284 | Voltage-dependent L-type calcium | inhibitor | |
4 | O60840_DB04855 | O60840 | Voltage-dependent L-type calcium | inhibitor | |
5 | Q08289_DB04855 | Q08289 | Voltage-dependent L-type calcium | inhibitor | |
6 | O95069_DB04855 | O95069 | Potassium channel subfamily | inhibitor | |
7 | P18825_DB04855 | P18825 | Alpha-2C adrenergic receptor | antagonist | |
8 | Q01668_DB04855 | Q01668 | Voltage-dependent L-type calcium | inhibitor | |
9 | P18089_DB04855 | P18089 | Alpha-2B adrenergic receptor | antagonist | |
10 | P51787_DB04855 | P51787 | Potassium voltage-gated channel | inhibitor | |
11 | P48549_DB04855 | P48549 | G protein-activated inward | inhibitor | |
12 | O00305_DB04855 | O00305 | Voltage-dependent L-type calcium | inhibitor | |
13 | P10827_DB04855 | P10827 | Thyroid hormone receptor | inhibitor | |
14 | P32418_DB04855 | P32418 | Sodium/calcium exchanger 1 | inhibitor | |
15 | Q12809_DB04855 | Q12809 | Voltage-gated inwardly rectifying | inhibitor | IC50(nM) = 316.23 |
16 | P25100_DB04855 | P25100 | Alpha-1D adrenergic receptor | antagonist | |
17 | Q9UK17_DB04855 | Q9UK17 | A-type voltage-gated potassium | inhibitor | |
18 | P35368_DB04855 | P35368 | Alpha-1B adrenergic receptor | antagonist | |
19 | P35348_DB04855 | P35348 | Alpha-1A adrenergic receptor | antagonist | |
20 | P08588_DB04855 | P08588 | Beta-1 adrenergic receptor | antagonist | |
21 | Q02641_DB04855 | Q02641 | Voltage-dependent L-type calcium | inhibitor | |
22 | Q14524_DB04855 | Q14524 | Sodium channel protein | inhibitor | |
23 | Q13936_DB04855 | Q13936 | Voltage-dependent L-type calcium | inhibitor |